Iron Chelators Inhibit the Growth and Induce the Apoptosis of Kaposi's Sarcoma Cells and of their Putative Endothelial Precursors
- 1 November 2000
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 115 (5) , 893-900
- https://doi.org/10.1046/j.1523-1747.2000.00119.x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Overexpression of Bcl-2 in Kaposi's Sarcoma-Derived CellsJournal of Investigative Dermatology, 1998
- Ordering the Cell Death PathwayJournal of Biological Chemistry, 1996
- Overexpression of the Bcl-2 Protein Increases the Half-life of p21BaxJournal of Biological Chemistry, 1995
- Establishment and characterization of two new Kaposi's sarcoma cell cultures from an AIDS and a non-AIDS patientResearch in Virology, 1994
- G1 phase progression: Cycling on cueCell, 1994
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaNature, 1994
- Iron deprivation‐induced apoptosis in HL‐60 cellsFEBS Letters, 1994
- Iron in CancerPathobiology, 1992
- Comparative activity of selected antiviral compounds against clinical isolates of human cytomegalovirusEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Cytotoxic and DNA‐inhibitory effects of iron chelators on human leukaemic cell linesHematological Oncology, 1986